title: The effect of intraperitoneal administration of sodium tolmetin-hyaluronic acid on the postsurgical cell infiltration in vivo.
abstract: Intraperitoneal administration of sodium tolmetin-hyaluronic acid reduced the formation of adhesions at early postsurgical time points. In addition, at 6, 48, 72, and 96 hr following surgery, there was a significant reduction in the number of red blood cells (RBC) recovered from peritoneal lavage. This effect was not the result of fluid or viscous solution in the peritoneal cavity since intraperitoneal administration of Ringer's lactate or Hyskon (a 32% solution of Dextran 70) did not affect RBC recovery. In contrast, the influx of leukocytes into the peritoneal cavity was elevated at 12 hr after surgery, but suppressed at 96 hr. These data may suggest a mechanism by which sodium tolmetin in hyaluronic acid reduced adhesion formation.
authors.affiliation: Department of Obstetrics and Gynecology, University of Southern California, School of Medicine, Los Angeles 90033.
authors.forename: H
authors.initials: H
authors.lastname: Abe
authors.forename: K E
authors.initials: KE
authors.lastname: Rodgers
authors.forename: J D
authors.initials: JD
authors.lastname: Campeau
authors.forename: W
authors.initials: W
authors.lastname: Girgis
authors.forename: D
authors.initials: D
authors.lastname: Ellefson
authors.forename: G S
authors.initials: GS
authors.lastname: DiZerega
mesh_terms: D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage / Q000627:therapeutic use*; D004906:Erythrocyte Count; D004912:Erythrocytes / Q000473:pathology; D005260:Female; D006820:Hyaluronic Acid / Q000008:administration & dosage*; D007958:Leukocyte Count; D008264:Macrophages / Q000473:pathology; D009504:Neutrophils / Q000473:pathology; D010529:Peritoneal Cavity / Q000473:pathology; D010533:Peritoneal Lavage; D011183:Postoperative Complications; D011817:Rabbits; D013997:Time Factors; D000267:Tissue Adhesions / Q000209:etiology / Q000473:pathology / Q000517:prevention & control*; D014046:Tolmetin / Q000008:administration & dosage / Q000627:therapeutic use*; D014599:Uterus / Q000601:surgery
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D006820:Hyaluronic Acid; D014046:Tolmetin